Keegan BM, Dreitzler AL, Sexton T, Beveridge TJR, Smith HR, Miller MD, Blough BE, Porrino LJ, Childers SR, Howlett AC. Chronic phenmetrazine treatment promotes D2 dopaminergic and a2-adrenergic receptor desensitization and alters phosphorylation of signaling proteins and local cerebral glucose metabolism in the rat brain. Brain Res. 2021 Feb 23; 1761:147387.